Top Menu

Author Archive | admin

PPHT-square

PatientPoint, Outcome Health Combine to Form PatientPoint Health Technologies

It was announced earlier this month that PatientPoint had combined forces with Outcome Health to launch a new platform company, PatientPoint Health Technologies. Functioning under the PatientPoint brand, this merger amplifies doctor-patient interactions across the entire patient care journey and, as noted in the release, helps “meet the tech-enabled patient engagement needs of nearly 150,000 […]

Continue Reading 0
OgilvyHealth-eCards

#EverydayMatters: A Year of Raising Cancer Awareness

With World Cancer Day on Feb 4, 2021, Ogilvy Health closed in on their year-long commitment to cancer awareness through their passion project, #EverydayMatters. DTC Perspectives spoke with two of the team members behind the campaign for its launch and again in late summer for an update. Coming full circle, we spoke with Deb Ciauro, […]

Continue Reading 0
Phreesia-telemedicine-visits-chart

Outpatient Visits Steady Despite COVID Surge, Shows Latest Research from Phreesia, Harvard, & Commonwealth Fund

In analyzing data from November and December for its sixth wave of research, the Commonwealth Fund, Phreesia, & Harvard found that, even though there was another surge of COVID-19 cases largely across the country, the number of outpatient practice visits remained stable. When compared to the baseline week of March 1, the November and December […]

Continue Reading 0

KFF Analyzes Racial / Ethnic Disparities in COVID-19 Vaccinations

Ensuring equitable access to COVID-19 vaccines has been a top concern in the rollout process. According to a brief by the Kaiser Family Foundation (KFF), “National recommendations regarding vaccine distribution have emphasized the importance of ensuring equitable access, particularly for disproportionately affected groups, including people of color.” KFF identified some key barriers when it comes […]

Continue Reading 0
Xpectives.Health-logo-Square

Announcing Xpectives.Health – Conferences Focused on Understanding the Healthcare Consumer: Brought to you by DTC Perspectives

DTC Perspectives was organized in 2000 to focus on pharmaceutical marketing and in 2001 we launched The DTC National. In later years we organized conferences on Hospital Marketing, Multicultural Communications, OTC Marketing, and Disease Education. To better describe what we do, we are excited to refer to our conference series as Xpectives.Health. We see our […]

Continue Reading 0

Biden-Harris Administration to Re-Open Enrollment, Re-Examine Other Health Policies

Announced today, President Biden is set to sign two Executive Orders in his efforts to improve health care access and affordability to Americans. The Department of Health and Human Services (HHS) is expected to re-open a “Special Enrollment Period” this year to the Health Insurance Marketplace, from Feb. 15-May 15, allowing citizens in need of […]

Continue Reading 0
syringe-5873159_1920

US Gov’t in Talks to Purchase Additional 100 Million Doses Each of Pfizer-BioNTech & Moderna COVID-19 Vaccines

As part of President Biden’s National Action Strategy to combat the global pandemic, he has instructed his COVID-19 Response Coordinator to work with the Department of Health and Human Services (HHS) in securing an additional 100 million doses of each of the two COVID-19 vaccines that have been approved by the FDA from Pfizer-BioNTech and […]

Continue Reading 0
POC3-LOGO-LRG

PoC3 Updates Verification & Validation Guidance, Issues Certifications to Five Companies

The Point of Care Communication Council, PoC3, updated its official guidance regarding Verification and Validation. The 2021 guidance provides three major changes: the expansion of network audits to include a company’s asset management system’s internal control and procedures;the volume of campaign audits required for certification will be based on annual campaign volume (not individual campaign […]

Continue Reading 0

Pfizer, BioNTech Announce Final Efficacy Analysis from Phase 3 Study of their COVID Vaccine Candidate

Early this morning, Pfizer and BioNTech issued a news release stating that the Phase 3 study of their MRNA-based COVID-19 vaccine met all primary efficacy endpoints. “Analysis of the data indicates a vaccine efficacy rate of 95% (p<0.0001) in participants without prior SARS-CoV-2 infection (first primary objective) and also in participants with and without prior […]

Continue Reading 0